ArticleCardiovascular drugs and therapy2018

Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.

Norihide Fukushima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.